Anthony Digiandomenico, Director at ENDRA Life Sciences Inc. (NDRA), bought 166,666 shares at $1.20 ($200K) on 2023-05-02, disclosed to the SEC on 2023-05-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.20 | 83,333 | $100K | 50.0% |
| 2 | $1.20 | 83,333 | $100K | 50.0% |
| Total | $1.20 avg | 166,666 | $200K | 100% |
| Filing → |
| MDBH | BUY | 2025-02-14 | $8K | — | Filing → |
| MDBH | BUY | 2025-02-11 | $12K | — | Filing → |
| MDBH | BUY | 2025-02-06 | $4K | — | Filing → |